$SFES
SAFEGUARD SCIENTIFICS INC

2011 Q4 Form 10-K Financial Statement

#000119312513099108 Filed on March 11, 2013

View on sec.gov

Income Statement

Concept 2011 Q4 2011 Q3 2011 Q2
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $5.600M $5.100M $5.600M
YoY Change -1.75% 45.71% 47.37%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $5.600M $5.100M $5.600M
YoY Change 0.0% 45.71% 47.37%
Operating Profit -$5.614M -$5.100M -$5.570M
YoY Change -17.44% 18.6% 13.67%
Interest Expense -$14.20M $27.80M $128.2M
YoY Change 22.41% -942.42% -1985.29%
% of Operating Profit
Other Income/Expense, Net -$4.754M -$324.0K -$775.0K
YoY Change -107.47% -104.0% -105.38%
Pretax Income -$24.54M $22.33M $121.8M
YoY Change -154.41% 3621.83% 4411.67%
Income Tax
% Of Pretax Income
Net Earnings -$24.54M $22.33M $121.8M
YoY Change -154.41% 3621.83% 4411.67%
Net Earnings / Revenue
Basic Earnings Per Share -$1.18 $1.07 $5.87
Diluted Earnings Per Share -$1.18 $0.98 $5.05
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2011 Q4 2011 Q3 2011 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $241.3M $265.4M $254.7M
YoY Change 6.86% 380.8% 267.0%
Cash & Equivalents $83.19M $144.2M $203.4M
Short-Term Investments $158.1M $121.1M $51.20M
Other Short-Term Assets $12.70M $12.90M $12.60M
YoY Change 4.96% 7.5% 5.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $253.9M $278.2M $267.2M
YoY Change 6.74% 313.99% 228.26%
LONG-TERM ASSETS
Property, Plant & Equipment $228.0K $300.0K $200.0K
YoY Change -24.0% 0.0% -33.33%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $110.3M $138.1M $137.5M
YoY Change 28.74% -31.8% -21.83%
Other Assets $2.117M $7.700M $10.10M
YoY Change -83.2% -39.37% -32.67%
Total Long-Term Assets $152.7M $146.1M $147.8M
YoY Change 54.87% -32.17% -22.7%
TOTAL ASSETS
Total Short-Term Assets $253.9M $278.2M $267.2M
Total Long-Term Assets $152.7M $146.1M $147.8M
Total Assets $406.6M $424.3M $415.0M
YoY Change 20.84% 50.14% 52.24%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $243.0K $200.0K $300.0K
YoY Change -51.4% 0.0% 0.0%
Accrued Expenses $8.300M $7.500M $7.600M
YoY Change -1.19% 29.31% 18.75%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
Total Short-Term Liabilities $8.516M $7.800M $7.900M
YoY Change -78.82% -79.09% -79.21%
LONG-TERM LIABILITIES
Long-Term Debt $45.70M $45.50M $45.40M
YoY Change 2.47% 2.25% 2.48%
Other Long-Term Liabilities $4.146M $4.100M $4.200M
YoY Change -21.77% -21.15% -19.23%
Total Long-Term Liabilities $4.146M $49.60M $49.60M
YoY Change -91.69% -0.2% 0.2%
TOTAL LIABILITIES
Total Short-Term Liabilities $8.516M $7.800M $7.900M
Total Long-Term Liabilities $4.146M $49.60M $49.60M
Total Liabilities $12.66M $57.40M $57.50M
YoY Change -85.95% -33.95% -34.36%
SHAREHOLDERS EQUITY
Retained Earnings -$464.7M
YoY Change
Common Stock $813.0M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $348.3M $366.9M $357.6M
YoY Change
Total Liabilities & Shareholders Equity $406.6M $424.3M $415.0M
YoY Change 20.84% 50.14% 52.24%

Cashflow Statement

Concept 2011 Q4 2011 Q3 2011 Q2
OPERATING ACTIVITIES
Net Income -$24.54M $22.33M $121.8M
YoY Change -154.41% 3621.83% 4411.67%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$4.100M -$3.200M -$3.100M
YoY Change 10.81% -3.03% 14.81%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$100.0K $0.00
YoY Change 0.0%
Acquisitions
YoY Change
Other Investing Activities -$57.20M -$56.20M $110.9M
YoY Change -136.11% -1618.92% -1707.25%
Cash From Investing Activities -$57.20M -$56.30M $110.9M
YoY Change -136.13% -1621.62% -1707.25%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 300.0K 300.0K 200.0K
YoY Change 200.0% 200.0% -166.67%
NET CHANGE
Cash From Operating Activities -4.100M -3.200M -3.100M
Cash From Investing Activities -57.20M -56.30M 110.9M
Cash From Financing Activities 300.0K 300.0K 200.0K
Net Change In Cash -61.00M -59.20M 108.0M
YoY Change -139.43% -11940.0% -1190.91%
FREE CASH FLOW
Cash From Operating Activities -$4.100M -$3.200M -$3.100M
Capital Expenditures $0.00 -$100.0K $0.00
Free Cash Flow -$4.100M -$3.100M -$3.100M
YoY Change 10.81% -3.13% 14.81%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2009Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
190507000
CY2009Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.51
CY2009Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
67347000
CY2009Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3268000 shares
CY2010Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
246431000
CY2010Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.83
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
183419000
CY2010Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3321000 shares
CY2010Q4 us-gaap Accumulated Other Comprehensive Income Loss Other Than Temporary Impairment Not Credit Loss Net Of Tax Availableforsale Debt Securities
AccumulatedOtherComprehensiveIncomeLossOtherThanTemporaryImpairmentNotCreditLossNetOfTaxAvailableforsaleDebtSecurities
1108000
CY2011Q4 us-gaap Equity Method Investment Summarized Financial Information Equity
EquityMethodInvestmentSummarizedFinancialInformationEquity
130984000
CY2011Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1081000
CY2011Q4 us-gaap Available For Sale Securities Noncurrent
AvailableForSaleSecuritiesNoncurrent
5184000
CY2011Q4 us-gaap Equity Method Investments
EquityMethodInvestments
110329000
CY2011Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1544000
CY2011Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
120132000
CY2011Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
810956000
CY2011Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
CY2011Q4 us-gaap Escrow Deposit
EscrowDeposit
6433000
CY2011Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2117000
CY2011Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Other
DeferredTaxAssetsTaxDeferredExpenseOther
50041000
CY2011Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
3690000
CY2011Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2011Q4 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
158098000
CY2011Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
348280000
CY2011Q4 us-gaap Equity Method Investment Summarized Financial Information Current Liabilities
EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities
64568000
CY2011Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
83333000 shares
CY2011Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
5137000
CY2011Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4583000
CY2011Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20752000 shares
CY2011Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
7580000
CY2011Q4 us-gaap Accounts Payable Other Current And Noncurrent
AccountsPayableOtherCurrentAndNoncurrent
2287000
CY2011Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
243000
CY2011Q4 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
7587000
CY2011Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1047000
CY2011Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4146000
CY2011Q4 us-gaap Equity Method Investment Summarized Financial Information Current Assets
EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets
156497000
CY2011Q4 us-gaap Valuation Allowance Amount
ValuationAllowanceAmount
120132000
CY2011Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2011Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
59626000
CY2011Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-464710000
CY2011Q4 us-gaap Assets
Assets
406636000
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
10.32
CY2011Q4 us-gaap Accounts Payable Interest Bearing Current And Noncurrent
AccountsPayableInterestBearingCurrentAndNoncurrent
1403000
CY2011Q4 us-gaap Equity Method Investment Summarized Financial Information Assets
EquityMethodInvestmentSummarizedFinancialInformationAssets
229408000
CY2011Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
45694000
CY2011Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
1838000
CY2011Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2011Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
406636000
CY2011Q4 us-gaap Cost Method Investments
CostMethodInvestments
2984000
CY2011Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
7128000
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
83187000
CY2011Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20752000 shares
CY2011Q4 us-gaap Equity Method Investment Summarized Financial Information Noncurrent Assets
EquityMethodInvestmentSummarizedFinancialInformationNoncurrentAssets
72911000
CY2011Q4 us-gaap Equity Method Investment Summarized Financial Information Noncurrent Liabilities
EquityMethodInvestmentSummarizedFinancialInformationNoncurrentLiabilities
33856000
CY2011Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-41000
CY2011Q4 us-gaap Equity Method Investment Summarized Financial Information Liabilities And Equity
EquityMethodInvestmentSummarizedFinancialInformationLiabilitiesAndEquity
229408000
CY2011Q4 us-gaap Liabilities Current
LiabilitiesCurrent
8516000
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3218000 shares
CY2011Q4 us-gaap Common Stock Value
CommonStockValue
2075000
CY2011Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2011Q4 us-gaap Assets Current
AssetsCurrent
253936000
CY2011Q4 us-gaap Accumulated Other Comprehensive Income Loss Other Than Temporary Impairment Not Credit Loss Net Of Tax Availableforsale Debt Securities
AccumulatedOtherComprehensiveIncomeLossOtherThanTemporaryImpairmentNotCreditLossNetOfTaxAvailableforsaleDebtSecurities
7451000
CY2011Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2011Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2011Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1316000
CY2011Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
228000
CY2011Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
114169000
CY2011Q4 us-gaap Held To Maturity Securities Noncurrent
HeldToMaturitySecuritiesNoncurrent
16287000
CY2011Q4 sfe Cash Collateral Received
CashCollateralReceived
100000
CY2011Q4 sfe Advances To Joint Interest Partners
AdvancesToJointInterestPartners
856000
CY2011Q4 sfe Allowance For Loan Losses
AllowanceForLoanLosses
0
CY2012Q4 us-gaap Equity Method Investment Summarized Financial Information Equity
EquityMethodInvestmentSummarizedFinancialInformationEquity
79926000
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2408000
CY2012Q4 us-gaap Available For Sale Securities Noncurrent
AvailableForSaleSecuritiesNoncurrent
58000
CY2012Q4 us-gaap Equity Method Investments
EquityMethodInvestments
106741000
CY2012Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1609000
CY2012Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
139330000
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
252000 shares
CY2012Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
815946000
CY2012Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
CY2012Q4 us-gaap Escrow Deposit
EscrowDeposit
6434000
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3272000
CY2012Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Other
DeferredTaxAssetsTaxDeferredExpenseOther
52602000
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1320000 shares
CY2012Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
2601000
CY2012Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
0
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2012Q4 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
110957000
CY2012Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
6646000
CY2012Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
313971000
CY2012Q4 us-gaap Equity Method Investment Summarized Financial Information Current Liabilities
EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities
125491000
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
83333000 shares
CY2012Q4 us-gaap Guarantee Obligations Maximum Exposure
GuaranteeObligationsMaximumExposure
3800000
CY2012Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
10000
CY2012Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4050000
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
9.93
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
14146000
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20968000 shares
CY2012Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
500000
CY2012Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
7942000
CY2012Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
600000
CY2012Q4 us-gaap Accounts Payable Other Current And Noncurrent
AccountsPayableOtherCurrentAndNoncurrent
2266000
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
610000
CY2012Q4 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
7085000
CY2012Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1557000
CY2012Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3921000
CY2012Q4 us-gaap Equity Method Investment Summarized Financial Information Current Assets
EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets
168246000
CY2012Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
0
CY2012Q4 us-gaap Valuation Allowance Amount
ValuationAllowanceAmount
139330000
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2012Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
75369000
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-504072000
CY2012Q4 us-gaap Assets
Assets
374144000
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
10.72
CY2012Q4 us-gaap Accounts Payable Interest Bearing Current And Noncurrent
AccountsPayableInterestBearingCurrentAndNoncurrent
335000
CY2012Q4 us-gaap Equity Method Investment Summarized Financial Information Assets
EquityMethodInvestmentSummarizedFinancialInformationAssets
242801000
CY2012Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
48991000
CY2012Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
1860000
CY2012Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
204209000
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
374144000
CY2012Q4 us-gaap Cost Method Investments
CostMethodInvestments
12634000
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
13113000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
66029000
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20968000 shares
CY2012Q4 us-gaap Equity Method Investment Summarized Financial Information Noncurrent Assets
EquityMethodInvestmentSummarizedFinancialInformationNoncurrentAssets
74555000
CY2012Q4 us-gaap Equity Method Investment Summarized Financial Information Noncurrent Liabilities
EquityMethodInvestmentSummarizedFinancialInformationNoncurrentLiabilities
37384000
CY2012Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
0
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
2854000 shares
CY2012Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
4000000 shares
CY2012Q4 us-gaap Equity Method Investment Summarized Financial Information Liabilities And Equity
EquityMethodInvestmentSummarizedFinancialInformationLiabilitiesAndEquity
242801000
CY2012Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures Fair Value Disclosure
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVenturesFairValueDisclosure
20972000
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7261000
CY2012Q4 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
58300000
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3287000 shares
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
2097000
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2012Q4 us-gaap Assets Current
AssetsCurrent
185838000
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Other Than Temporary Impairment Not Credit Loss Net Of Tax Availableforsale Debt Securities
AccumulatedOtherComprehensiveIncomeLossOtherThanTemporaryImpairmentNotCreditLossNetOfTaxAvailableforsaleDebtSecurities
260000
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2010 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
106000
CY2010 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
631000
CY2010 us-gaap Profit Loss
ProfitLoss
26609000
CY2010 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000 pure
CY2010 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-16019000
CY2010 us-gaap Equity Method Investment Summarized Financial Information Income Loss From Continuing Operations Before Extraordinary Items
EquityMethodInvestmentSummarizedFinancialInformationIncomeLossFromContinuingOperationsBeforeExtraordinaryItems
162397000
CY2010 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
131856000
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1416000
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
193000
CY2012Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
148639000
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
10.39
CY2012Q4 us-gaap Held To Maturity Securities Noncurrent
HeldToMaturitySecuritiesNoncurrent
29059000
CY2012Q4 sfe Net Operating Loss Carryforwards Expiring In Year One
NetOperatingLossCarryforwardsExpiringInYearOne
CY2012Q4 sfe Net Operating Loss Carryforwards Expiring In Year Two
NetOperatingLossCarryforwardsExpiringInYearTwo
CY2012Q4 sfe Net Operating Loss Carryforwards Expiring In Year Three
NetOperatingLossCarryforwardsExpiringInYearThree
CY2012Q4 sfe Net Operating Loss Carryforwards Expiring In Year Four
NetOperatingLossCarryforwardsExpiringInYearFour
CY2012Q4 sfe Net Operating Loss Carryforwards Expiring In Year Thereafter
NetOperatingLossCarryforwardsExpiringInYearThereafter
204209000
CY2012Q4 sfe Advances To Joint Interest Partners
AdvancesToJointInterestPartners
8292000
CY2012Q4 sfe Allowance For Loan Losses
AllowanceForLoanLosses
2000000
CY2012Q4 sfe Equity Method Investment Assets Exceed Carrying Value Of Investment
EquityMethodInvestmentAssetsExceedCarryingValueOfInvestment
68700000
CY2012Q4 sfe Partner Companies Not Accounted For In Financial Statement
PartnerCompaniesNotAccountedForInFinancialStatement
18 Entity
CY2012Q4 sfe Impaired Loans Carrying Amount
ImpairedLoansCarryingAmount
0
CY2013Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
20976963 shares
CY2012Q2 dei Entity Public Float
EntityPublicFloat
316924470
CY2012Q3 sfe Percentage Of Limited Partnership Interest
PercentageOfLimitedPartnershipInterest
0.094 pure
CY2012Q3 sfe Company Funded For Early And Growth Stage
CompanyFundedForEarlyAndGrowthStage
400000
CY2001Q2 sfe Loan Agreement With Related Party
LoanAgreementWithRelatedParty
26500000
CY2008Q2 us-gaap Proceeds From Divestiture Of Businesses And Interests In Affiliates
ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates
6400000
CY2010 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
10.10
CY2010 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
0
CY2010 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
400000
CY2010 us-gaap Operating Income Loss
OperatingIncomeLoss
-20847000
CY2010 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1107000
CY2010 us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
65201000
CY2010 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
74809000
CY2010 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.107 pure
CY2010 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3777000
CY2010 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
20418000
CY2010 us-gaap Payments For Advance To Affiliate
PaymentsForAdvanceToAffiliate
11710000
CY2010 us-gaap Other Income
OtherIncome
711000
CY2010 us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
63247000
CY2010 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
121000
CY2010 us-gaap Equity Method Investment Summarized Financial Information Revenue
EquityMethodInvestmentSummarizedFinancialInformationRevenue
238477000
CY2010 us-gaap Share Based Compensation
ShareBasedCompensation
3777000
CY2010 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
14.65
CY2010 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.017 pure
CY2010 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.24
CY2010 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
12.13
CY2010 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
21.36
CY2010 us-gaap Investment Income Interest
InvestmentIncomeInterest
718000
CY2010 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
872000
CY2010 us-gaap Income Taxes Paid
IncomeTaxesPaid
0
CY2010 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
1108000
CY2010 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
9.16
CY2010 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
116072000
CY2010 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
20847000
CY2010 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
224000 shares
CY2010 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21507000 shares
CY2010 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1107000
CY2010 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
195000
CY2010 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
12816000
CY2010 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.30
CY2010 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
235000
CY2010 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
300000
CY2010 us-gaap Interest Expense Debt
InterestExpenseDebt
5737000
CY2010 us-gaap Proceeds From Divestiture Of Businesses And Interests In Affiliates
ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates
183813000
CY2010 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
50000 shares
CY2010 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20535000 shares
CY2010 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
500000
CY2010 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350 pure
CY2010 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-22334000
CY2010 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.474 pure
CY2010 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
5718000
CY2010 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3777000
CY2010 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
26609000
CY2010 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
2700000
CY2010 us-gaap Interest Paid
InterestPaid
1500000
CY2010 us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
-23397000
CY2010 us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
0
CY2010 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
142000
CY2010 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
426000
CY2010 us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
18864000
CY2010 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
26609000
CY2010 us-gaap Proceeds From Collection Of Advance To Affiliate
ProceedsFromCollectionOfAdvanceToAffiliate
2009000
CY2010 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2010 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
477000
CY2010 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
39425000
CY2010 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
11708000
CY2010 us-gaap Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
61856000
CY2010 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
7.42
CY2010 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
10842000
CY2010 sfe Gains And Losses Due To Changes In Fair Value
GainsAndLossesDueToChangesInFairValue
-22394000
CY2011 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
18.78
CY2011 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
0
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
900000
CY2011 us-gaap Operating Income Loss
OperatingIncomeLoss
-21168000
CY2011 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
918000
CY2011 us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
240367000
CY2011 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-6145000
CY2011 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3052000
CY2011 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
85329000
CY2011 us-gaap Payments For Advance To Affiliate
PaymentsForAdvanceToAffiliate
12127000
CY2011 us-gaap Other Income
OtherIncome
1306000
CY2011 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
124000
CY2011 us-gaap Equity Method Investment Summarized Financial Information Revenue
EquityMethodInvestmentSummarizedFinancialInformationRevenue
116957000
CY2011 us-gaap Share Based Compensation
ShareBasedCompensation
3052000
CY2011 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
16.55
CY2011 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.003 pure
CY2011 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.74
CY2011 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
11.03
CY2011 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
21.36
CY2011 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
58000
CY2011 us-gaap Profit Loss
ProfitLoss
110597000
CY2011 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000 pure
CY2011 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-17727000
CY2011 us-gaap Equity Method Investment Summarized Financial Information Income Loss From Continuing Operations Before Extraordinary Items
EquityMethodInvestmentSummarizedFinancialInformationIncomeLossFromContinuingOperationsBeforeExtraordinaryItems
63009000
CY2011 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-52575000
CY2011 us-gaap Investment Income Interest
InvestmentIncomeInterest
1424000
CY2011 us-gaap Income Taxes Paid
IncomeTaxesPaid
0
CY2011 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
7451000
CY2011 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
11.32
CY2011 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-100232000
CY2011 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
21168000
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
314000 shares
CY2011 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24522000 shares
CY2011 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
918000
CY2011 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
30848000
CY2011 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
429000
CY2011 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-12857000
CY2011 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
5.33
CY2011 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-29930000
CY2011 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
300000
CY2011 us-gaap Interest Expense Debt
InterestExpenseDebt
5971000
CY2011 us-gaap Proceeds From Divestiture Of Businesses And Interests In Affiliates
ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates
171268000
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
293000 shares
CY2011 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20764000 shares
CY2011 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
500000
CY2011 us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
5750000
CY2011 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350 pure
CY2011 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
142457000
CY2011 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.353 pure
CY2011 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
4618000
CY2011 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-107000
CY2011 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3052000
CY2011 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
110597000
CY2011 us-gaap Interest Paid
InterestPaid
400000
CY2011 us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
-38837000
CY2011 us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
0
CY2011 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
139000
CY2011 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
623000
CY2011 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
116347000
CY2011 us-gaap Proceeds From Collection Of Advance To Affiliate
ProceedsFromCollectionOfAdvanceToAffiliate
5000000
CY2011 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2011 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
1000
CY2011 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
97740000
CY2011 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-20308000
CY2011 us-gaap Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
108393000
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
8.28
CY2011 sfe Origination Fees On Loans
OriginationFeesOnLoans
537000
CY2012 dei Trading Symbol
TradingSymbol
SFE
CY2012 dei Entity Registrant Name
EntityRegistrantName
SAFEGUARD SCIENTIFICS INC
CY2012 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2012 dei Amendment Flag
AmendmentFlag
false
CY2012 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2012 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2012 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2012 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2012
CY2012 dei Document Type
DocumentType
10-K
CY2012 dei Document Period End Date
DocumentPeriodEndDate
2012-12-31
CY2012 dei Entity Central Index Key
EntityCentralIndexKey
0000086115
CY2012 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2012 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2012 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
3.93
CY2012 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
0
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1200000
CY2012 us-gaap Operating Income Loss
OperatingIncomeLoss
-19473000
CY2012 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1744000
CY2012 us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
242023000
CY2012 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P2Y3M26D
CY2012 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
9338000
CY2012 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2014000
CY2012 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
46100000
CY2012 us-gaap Proceeds From Collection Of Loans Receivable
ProceedsFromCollectionOfLoansReceivable
16900000
CY2012 us-gaap Payments For Advance To Affiliate
PaymentsForAdvanceToAffiliate
13665000
CY2012 us-gaap Other Income
OtherIncome
293000
CY2012 us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
9004000
CY2012 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P3Y18D
CY2012 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
108000
CY2012 us-gaap Equity Method Investment Summarized Financial Information Revenue
EquityMethodInvestmentSummarizedFinancialInformationRevenue
188989000
CY2012 us-gaap Share Based Compensation
ShareBasedCompensation
2014000
CY2012 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
14.91
CY2012 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.003 pure
CY2012 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.88
CY2012 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
13.48
CY2012 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
18.80
CY2012 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
-7701000
CY2012 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
73000
CY2012 us-gaap Profit Loss
ProfitLoss
-39362000
CY2012 us-gaap Defined Contribution Plan Maximum Annual Contribution Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionPerEmployeePercent
0.75 pure
CY2012 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000 pure
CY2012 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-16525000
CY2012 us-gaap Equity Method Investment Summarized Financial Information Income Loss From Continuing Operations Before Extraordinary Items
EquityMethodInvestmentSummarizedFinancialInformationIncomeLossFromContinuingOperationsBeforeExtraordinaryItems
97403000
CY2012 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
3116000
CY2012 us-gaap Investment Income Interest
InvestmentIncomeInterest
2926000
CY2012 us-gaap Income Taxes Paid
IncomeTaxesPaid
0
CY2012 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
260000
CY2012 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
10.22
CY2012 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-17158000
CY2012 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
19473000
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
293000 shares
CY2012 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20974000 shares
CY2012 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1741000
CY2012 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
58703000
CY2012 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
418000
CY2012 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
41000
CY2012 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.88
CY2012 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3749000
CY2012 us-gaap Other Comprehensive Income Loss Reclassification Adjustment For Sale Of Securities Included In Net Income Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax
-4607000
CY2012 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
300000
CY2012 us-gaap Interest Expense Debt
InterestExpenseDebt
5636000
CY2012 us-gaap Proceeds From Divestiture Of Businesses And Interests In Affiliates
ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates
17596000
CY2012 us-gaap Interest Paid
InterestPaid
800000
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
13000 shares
CY2012 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20974000 shares
CY2012 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
600000
CY2012 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
-0.35 pure
CY2012 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-26517000
CY2012 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y6M18D
CY2012 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.347 pure
CY2012 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
3228000
CY2012 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2014000
CY2012 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-39362000
CY2012 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
400000
CY2012 us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
-78142000
CY2012 us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
0
CY2012 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
94000
CY2012 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
726000
CY2012 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
-39362000
CY2012 us-gaap Proceeds From Collection Of Advance To Affiliate
ProceedsFromCollectionOfAdvanceToAffiliate
3214000
CY2012 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
55000000
CY2012 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2012 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-39321000
CY2012 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Accounting Estimates</i></b></font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The preparation of the Consolidated Financial Statements in accordance with accounting principles generally accepted in the United States of America requires management to make estimates and judgments that affect amounts reported in the financial statements and accompanying notes. Actual results may differ from these estimates. These estimates include the evaluation of the recoverability of the Company&#x2019;s ownership interests in and advances to partner companies and funds and investments in marketable securities, income taxes, stock-based compensation and commitments and contingencies. Management evaluates its estimates on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances.</font></p> <p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px; FONT-SIZE: 1px"> &#xA0;</p> <p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Certain amounts recorded to reflect the Company&#x2019;s share of income or losses of partner companies accounted for under the equity method are based on unaudited results of operations of those companies and may require adjustments in the future when audits of these entities&#x2019; financial statements are completed.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">It is reasonably possible that the Company&#x2019;s accounting estimates with respect to the ultimate recoverability of the carrying value of the Company&#x2019;s ownership interests in and advances to partner companies and funds could change in the near term and that the effect of such changes on the financial statements could be material. At December&#xA0;31, 2012, the Company believes the carrying value of the Company&#x2019;s ownership interests in and advances to partner companies and funds is not impaired, although there can be no assurance that the Company&#x2019;s future results will confirm this assessment, that a significant write-down or write-off will not be required in the future, or that a significant loss will not be recorded in the future upon the sale of a company.</font></p> </div>
CY2012 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
4388000
CY2012 us-gaap Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
276392000
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
7.45
CY2012 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
6446000
CY2012 sfe Lease Expiration Year
LeaseExpirationYear
2016
CY2012 sfe Gains And Losses Due To Changes In Fair Value
GainsAndLossesDueToChangesInFairValue
-11035000
CY2012 sfe Loan Impairment Charge
LoanImpairmentCharge
15700000
CY2012 sfe Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt Acquired
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtAcquired
-5283000
CY2012 sfe Issuance Costs Related To Conversion Of Convertible Senior Notes
IssuanceCostsRelatedToConversionOfConvertibleSeniorNotes
1790000
CY2012 sfe Future Annual Payment To Chairman And Chief Executive Officer
FutureAnnualPaymentToChairmanAndChiefExecutiveOfficer
650000
CY2012 sfe Lease Guarantee Expiration Year
LeaseGuaranteeExpirationYear
2016
CY2012 sfe Origination Fees On Loans
OriginationFeesOnLoans
74000
CY2011Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-4884000
CY2011Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-292000
CY2011Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.46
CY2011Q1 us-gaap Profit Loss
ProfitLoss
-9010000
CY2011Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
367000
CY2011Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4884000
CY2011Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.44
CY2011Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
1636000
CY2011Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-2565000
CY2011Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9010000
CY2011Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2011Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-5570000
CY2011Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-775000
CY2011Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
5.05
CY2011Q2 us-gaap Profit Loss
ProfitLoss
121815000
CY2011Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
324000
CY2011Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5570000
CY2011Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
5.87
CY2011Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
1441000
CY2011Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
129277000
CY2011Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
121815000
CY2011Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2012Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-4743000
CY2012Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3084000
CY2012Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.46
CY2012Q1 us-gaap Profit Loss
ProfitLoss
-9660000
CY2012Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
899000
CY2012Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4743000
CY2012Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.46
CY2012Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
1452000
CY2012Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-7448000
CY2012Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9660000
CY2012Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2012Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-5148000
CY2012Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4819000
CY2012Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.48
CY2012Q2 us-gaap Profit Loss
ProfitLoss
-10137000
CY2012Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
595000
CY2012Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5148000
CY2012Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.48
CY2012Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
1456000
CY2012Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-8947000
CY2012Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10137000
CY2012Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2011Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-5614000
CY2011Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4754000
CY2011Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.18
CY2011Q4 us-gaap Profit Loss
ProfitLoss
-24539000
CY2011Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
455000
CY2011Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5614000
CY2011Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.18
CY2011Q4 us-gaap Interest Expense Debt
InterestExpenseDebt
1449000
CY2011Q4 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-13177000
CY2011Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-24539000
CY2011Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2012Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-4792000
CY2012Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1344000
CY2012Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.51
CY2011Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5100000
CY2011Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.07
CY2012Q4 us-gaap Profit Loss
ProfitLoss
-10808000
CY2012Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
736000
CY2012Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4792000
CY2012Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.51
CY2012Q4 us-gaap Interest Expense Debt
InterestExpenseDebt
1267000
CY2012Q4 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-6829000
CY2012Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.42
CY2012Q3 us-gaap Profit Loss
ProfitLoss
-8757000
CY2012Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
696000
CY2012Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4790000
CY2012Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.42
CY2012Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
1461000
CY2012Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-3293000
CY2012Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10808000
CY2012Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2012Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-4790000
CY2012Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
91000
CY2012Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8757000
CY2012Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2011Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-5100000
CY2011Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-324000
CY2011Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.98
CY2011Q3 us-gaap Profit Loss
ProfitLoss
22331000
CY2011Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
278000
CY2011Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
1445000
CY2011Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
28922000
CY2011Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
22331000
CY2011Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit

Files In Submission

Name View Source Status
0001193125-13-099108-index-headers.html Edgar Link pending
0001193125-13-099108-index.html Edgar Link pending
0001193125-13-099108.txt Edgar Link pending
0001193125-13-099108-xbrl.zip Edgar Link pending
d444237d10k.htm Edgar Link pending
d444237dex10103.htm Edgar Link pending
d444237dex1083.htm Edgar Link pending
d444237dex1093.htm Edgar Link pending
d444237dex141.htm Edgar Link pending
d444237dex211.htm Edgar Link pending
d444237dex231.htm Edgar Link pending
d444237dex311.htm Edgar Link pending
d444237dex312.htm Edgar Link pending
d444237dex321.htm Edgar Link pending
d444237dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
g444237g54h52.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
sfe-20121231.xml Edgar Link completed
sfe-20121231.xsd Edgar Link pending
sfe-20121231_cal.xml Edgar Link unprocessable
sfe-20121231_def.xml Edgar Link unprocessable
sfe-20121231_lab.xml Edgar Link unprocessable
sfe-20121231_pre.xml Edgar Link unprocessable
Show.js Edgar Link pending